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Introduction
Risk assessment for neurotoxicants relies
upon dose-effect and dose-response data,
most ofwhich are obtained from experi-
mental animal studies. Although the diffi-
culties in risk assessment for behavioral
effects were appreciated 20 years ago, a
report from the U.S. National Academy
of Sciences suggested that solutions could
be rapidly achieved (1). Progress has
been much slower than the optimistic
predictions, especially in neurobehavioral
epidemiology.
For the purpose ofrisk assessment, stud-
ies ofexposed human populations should
contribute information in the following four
areas: a) characterization of the types of
neurotoxicity that may occur as a result of
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the exposure, including progression or
reversal of the changes, so that the effects
can be evaluated with regard to their
adverse implications for human health;
b) the average degrees of the neurotoxic
effect caused by different magnitudes and
durations ofthe exposure (dose-effect rela-
tionship); c) the relative frequency ofa spe-
cific effect in response to different degrees
ofexposure (dose-response relationship);
and d) predisposing factors that may ren-
der particular individuals more susceptible
to the effects ofthe neurotoxic exposure.
For the most obvious neurotoxicants
such as several metals, solvents, and
pesticides, epidemiologic studies were not
needed to document that toxic effects
occurred in humans. Also, acute neurotoxi-
cityhas often been documented onlybycase
reports. However, the fact that a particular
chemical is neurotoxic does not contribute
much to the database needed for risk assess-
ment. Rather, this finding raises the need
for more advanced information.
Neurobehavioral epidemiology consists
ofthe disease-oriented neuroepidemiology
(which can be looked upon as a subdisci-
pline ofchronic-disease epidemiology) and
exposure-driven environmental epidemiol-
ogy. These two branches ofthe field gener-
ally correspond to case-control studies and
cohort studies, respectively.
Although neuroepidemiology has
enjoyed much attention, it is sad that a
recent monograph (2) mainly dealt with
major neurological diseases, and only one
chapter (on lead poisoning) focused on
adverse effects ofenvironmental exposures.
Similarly, neurobehavioral epidemiology is
often poorlyrepresented within the environ-
mental field. There are several reasons for
this relative lackofattention.
Ideally for risk assessment purposes, epi-
demiological studies should provide
unequivocal data on pathognomonic effects
where both the outcomes and the risk fac-
tors are accurately determined. The real
world offers few such occasions. Unfortu-
nately, because the nervous system is the tar-
get organ most commonly affected by
environmental chemicals, each ofthe clini-
cal signs and symptoms produced tends to
be nonspecific (3). In particular, the
chronic effects tend to be vague in the early
stages so that they fall within the normal
range or are indistinguishable from other
abnormalities. When evaluating such data,
other information from case reports or
experimental studies should be considered,
e.g., neurophysiologic and neuropatho-
logic evidence.
The neurobehavioral performance ofan
individual is affected by several factors
(Table 1). The particular outcome may
depend on characteristics ofthe exposure,
i.e., the severity and chronicity as well as
the question ofwhether other exposures
occurred at the same time. Also, the effect
depends on the vulnerability ofthe subject,
as indicated by, e.g., age and premorbid
status. Many neurotoxic effects are not sta-
tionary, and the outcome may therefore
depend on the patient's capability to com-
pensate for the damage, the extent ofpossi-
ble repair processes, and whether the
patient develops emotional reactions in
response to the impairment.
Although the types ofproblems encoun-
tered within neurobehavioral epidemiology
are in many respects similar to those seen in
environmental and occupational studies in
general (4-6), the difficulties encountered
in neurobehavioral epidemiology are partic-
ularly troublesome. This applies in particu-
lar to the operational choice of exposure
and outcome variables and the methods
used to determine them.
This paper will explore some of the
major obstacles using methylmercury as
an example. Although one of the best
documented human neurotoxicants, the
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Table 1. Factors that affect the neurobehavioral per-
formance ofan individual exposed to a neurotoxicant.
Exposure Magnitude
Duration
Concomitant factors
Individual Age(developmental stage)
Premorbid status
Preexisting diseases
Succession Compensation
Repair
Secondary reactions
evidence available on this chemical is far
from complete. The deficiencies seem to be
typical ofthe general field ofneurobehav-
ioral epidemiology.
Exposure Evaluation
The first step in risk assessment is hazard
identification in which the specific chemi-
cal or chemicals most likely to have caused
the neurobehavioral dysfunction should be
determined. This choice may be difficult
because exposures are often of a mixed
type. Having specified the chemical, the
magnitude of individual exposure levels
must then be assessed for the time inter-
val during which the toxic effect was
produced. In acute intoxication cases, expo-
sure evaluation can be relatively straightfor-
ward. However, serious problems occur,
e.g., with developmental dysfunctions
related to prenatal exposures orwith degen-
erative neurological disease associated with
exposures that perhaps occurred decades
before diagnosis.
When an outbreak ofMinamata disease
was discovered in Japan in the 1950s, the
cause ofthis serious neurological disorder
that especially affected newborns was not
known. No one knew which types ofsam-
ples might be needed for later analysis.
Fortunately, in this particular area ofJapan,
an ancient custom was to dry the umbilical
cord from each child and save it in a box.
When methylmercury eventually appeared
as a likely cause ofthe disease, umbilical
cords were collected from 12 patients who
had been born with congenital Minamata
disease and also from two control groups
(7). The methylmercury concentrations
were generally much higher in the cords of
Minamata disease patients. Some mis-
classification may have occurred, which
may explain the overlapping ofthe results.
However, the results should at least indicate
the magnitude ofthe causative exposure.
Unfortunately, as mercury concentrations
in umbilical cords are not routinely deter-
mined, the results are difficult to relate to
exposures in other populations. The corre-
lation between mercury concentrations in
cord tissue with those in maternal hair, the
most commonly used exposure indicator,
was therefore determined from samples
obtained in the Faroe Islands (8). From
the equation for the regression line, the
median maternal hair-mercury concentra-
tion for the Minamata disease group could
be calculated to be about 23 pg/g (115
nmol/g). Although a regression equation
obtained at another geographical location
using other analytical methods may not
accurately gauge the correlation under the
exposure conditions seen in Minamata, the
order ofmagnitude is probably not incor-
rect. However, as the group of patients
studied may represent only those with the
most severe congenital Minamata disease,
the hair-mercury level calculated should
not be interpreted as a threshold level for
methylmercury neurotoxicity. These data
illustrate how attempts at evaluating expo-
sure levels about 40 years ago may still be
relevant for risk assessments today.
In the subsequent outbreak of sub-
acute methylmercury poisoning in Iraq,
researchers chose to relate neurobehavioral
outcome to the peak hair-mercury concen-
trations, not taking into account when this
peak occurred in relation to the gestation
period (9,10). Whether the maximum
concentration was the best indicator ofan
exposure lasting for several months, this
parameter could be used with reasonable
confidence because it could be measured or
estimated in each ofthe patients. However,
when comparing these data to hair-mer-
cury concentrations from chronically-
exposed individuals, the question ofhow to
translate peak levels into long-term average
concentrations emerged. The variability of
mercury concentrations along the length of
the hair could depend on local and sea-
sonal factors. In hair samples from the
Faroe Islands, for example, the average
coefficient ofvariation for a series of 1.1-
cm hair segments from sixwomen was only
8.1 to 23.8% (11). Thus, in the Faroe
Islands population, with a series ofup to
twenty segments, for example, the maxi-
mum would therefore be expected to
remain well below 50% above the average.
It is doubtful whether the hair-mercury
concentration is always an accurate indica-
tor ofthe active amount ofmethylmercury
that has reached the nervous system, per-
haps over a long period oftime. Thus, sex-
related differences in whole-body dearance
and tissue distribution ofmethylmercury
have been demonstrated experimentally
(12,13). Interestingly, a recent study of
blood-mercury concentrations in a random
population sample showed significantly
higher values in women than in men, even
when adjusted for exposure factors (14).
Thus, sex-related differences in retention
may well affect currently used indicators of
mercury exposure.
The retention of mercury in the body
may also depend on other exposures. For
example, ethanol intake will increase the
formation of mercury vapor (Hg0) from
ionic mercury (Hg2+) in the blood, and
some of that Hg0 will be exhaled (15).
Accordingly, mercury-exposed human vol-
unteers tend to show a decreased concen-
tration ofinorganic mercury in blood after
alcohol ingestion (16). In a population
study in the Faroe Islands, the mercury
concentration in cord blood was signi-
ficandylowerwhen the motherhadingested
alcoholic beverages during pregnancy; the
median blood-mercury levels were 17%
lower in alcohol drinkers (11). Although
dietary differences may explain some ofthis
difference, a toxicokinetic interaction seems
likely. A parameter such as alcohol intake,
which may affect both the maternal expo-
sure indicator and the neurobehavioral out-
come in thechildren, could be an important
confounding factor in studies in neurobe-
havioral epidemiology.
Assessment of
Neurobehavioral Effects
Neurobehavioral function involves several
domains that can be evaluated by a multi-
tude ofmethods; the parameters ofchoice
should be sensitive to subtle effects ofthe
exposure but should not be affected
by other factors to a degree that would
obscure a relationship with the exposure
under study. Also, the earliest signs ofdys-
function should be assessed to provide the
best possible basis for decisions on preven-
tion. Guidance on which domains to eval-
uate should be obtained from previous
epidemiologic studies as well as from expe-
rience with human poisoning cases and
experimental evidence.
Especially with prenatal exposures, the
time ofthe neurobehavioral assessment is of
importance because the effects may not
become apparent until the nervous system
has matured sufficiently to express the dys-
functions (17). As mental sequelae can rarely
be reliably assessed at the time ofthe neuro-
toxic exposure, the developmental stage
(both at the time ofexposure and at the time
ofexamination) mustbe taken into consider-
ation. Also, during the interval between the
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exposure and the diagnostic testing, other
factors could affect development.
Much information was gathered on the
effects ofprenatal methylmercury exposure
on postnatal development from the
episodes of methylmercury poisoning in
Japan and Iraq (7,9,10). Although mile-
stone data and early developmental tests are
somewhat crude and have a limited predic-
tive validity with regard to subsequent cog-
nitive development, data collected in Iraq
have been used to establish dose-response
relationships. The peak mercury concentra-
tion in maternal hair during pregnancy was
used as an exposure indicator, and the effect
parameter included psychomotor retar-
dation (delayed walking and talking) and
an increased number ofabnormal neurolog-
ical signs (10,18). This information has
been a cornerstone for the determination of
safe exposure levels by the International
Programme on Chemical Safety (19).
In the Faroe Islands where high prenatal
exposures to methylmercury occur (11), the
age at which the child reached a develop-
mental milestone (sitting, creeping, rising)
was not associated with indices ofprenatal
mercury exposure, i.e., the mercury concen-
trations in umbilical cord blood and in
maternal hair. However, the milestone
development was associated with the hair-
mercury concentration at 12 months ofage,
but the correlation was in an unexpected
direction, i.e., indicating an advantage asso-
ciated with an increased exposure to mer-
cury (20). However, increased hair-mercury
concentrations at 12 months ofage were
significantly related to long duration of
nursing (21); thus, the association that was
found must therefore be due to confound-
ing by breast-feeding. Given the substantial
advantages ofbreast-feeding with regard to
milestone development (22), this factor
must be considered.
In patients with congenital Minamata
disease, mental retardation emerged as the
main sign ofthe disease in older children;
motor functions improved somewhat with
time. A study conducted in 1962 reported
that, of 72 Minamata children born from
1953 to 1954 and in 1959 (i.e., just
before and just after the highest pollution
period), 21 children (29%) had an IQ
below 70 (7). In 1971, schoolchildren
born in the Minamata area from 1955 to
1959 were examined, and high prevalences
ofmental retardation, sensory disturbance,
mild dysarthria, and adiadochokinesia were
observed (7). Unfortunately, detailed
information on the test methods that were
used is not available.
In a more recent population-based
study in New Zealand (23,24), 73 preg-
nantwomen were identified with hair-mer-
cury concentrations above 6 pg/g (30
nmol/g). A total of31 ofthe children born
were examined at 4 years ofage along with
matched controls who had low levels of
prenatal mercury exposure. In the Denver
Developmental Screening test, abnormal or
questionable results occurred three times
more often in the exposed group (23). At 6
to 7 years ofage, 61 ofthe children and
three control groups were tested by the
Wechsler Intelligence Scale for Children
(WISC); an average maternal hair-mercury
concentration ofabout 15 pg/g (75 nmol/g)
was found to be associated with decreased
test performance (24). While the methods
used in this study are well documented, the
omnibus tests chosen maybe useful onlyfor
producing an overall picture ofthe develop-
mental stage. These tests are not necessarily
sensitive to the effects ofmethylmercury
on the most vulnerable domains and could
well be affected by various confounding
factors (25).
Epidemiologic Strategies
Epidemiologic data are not a prerequisite
for risk assessment. In fact, opportunities
for epidemiologic studies ofneurotoxicity
may arise only when prevention has failed,
whether a risk assessment has been carried
out, and whether the origin ofthe exposure
is natural or anthropogenic. Given the fact
that neurotoxic exposures continue to
occur, the best possible epidemiologic stud-
ies should be carried out so that the unfor-
tunate incidents will at least result in useful
information that can provide a better basis
forintervention.
Due to the considerable imprecision in
the measurement ofboth exposure and neu-
robehavioral effects, such studies are subject
to high degrees ofbias and ofrandom mis-
classification. A major aim ofobtaining bet-
ter data in neurobehavioral epidemiology is
therefore to limit the imprecision and to
identify and measure the factors that may
affect the exposure parameters and the out-
comevariables.
Frequently, several exposure factors
must be determined because the exposure
under study is associated with other chemi-
cal exposures originating from the same
source. Accordingly, the hair-mercury con-
centration can be interpreted as a marker
ofseafood intake and may therefore also
serve as an indicator ofexposure to other
neurotoxic contaminants, such as polychlo-
rinated biphenyls, that are likely to occur
in marine food. Unfortunately, this poten-
tial source ofbias has notyet been explored
in detail. On the other hand, methyl-
mercury from seafood may occur in combi-
nation with selenium, which may attenuate
the toxic potential ofthe mercury.
In selecting the outcome variables, tests
should be chosen that are feasible but still
sensitive to dysfunctions ofthe domains
deemed to be affected by the exposure. The
results should be interpreted based on the
knowledge about the factors that could
affect the individual test and in relation to
the expected changes resulting from the
exposure to the neurotoxicant. However,
given the fact that neurobehavioral function
varies considerably within a population,
even similar exposure circumstances may be
associatedwithwidelydifferent performance
results in a group ofexposed subjects. Also,
despite results offunctional tests remaining
well within the expected interval, differ-
ences can still be considerable between
groups ofindividuals with different levels of
exposure. Further, the individual may not
be aware of any dysfunctions, but even
minimal changes can, in some cases, have
severe implications for dailylife. These con-
siderations are important to keep in mind
when interpreting neurobehavioral data.
To design a study in neurobehavioral
epidemiology, a proper source population
and a feasible sampling frame must be cho-
sen. An internal control group with mini-
mal exposure may be available within the
source population, but otherwise a suitable
comparison group must be identified.
These decisions apply to both case-control
studies and cohort studies. Awise choice of
source population and sampling strategy
may well circumvent some ofthe serious
bias problems.
The prospective cohort study is often
recommended as the most reliable source
ofinformation. However, this design does
not eliminate the need to control for the
imprecision ofexposure and outcome vari-
ables, and it may suffer from an additional
weakness, i.e., selection bias. Thus, the
study ofprenatal methylmercury exposure
carried out in New Zealand (23,24) suf-
fered from considerable attrition during the
follow-up period. Similar experiences have
been recorded in prospective studies oflead
neurotoxicity in children, in which the
annual loss to follow-up may be about 10%
(26). The children who remain in the
study could well differ substantially from
the original cohort. Likewise, prospective
studies ofexposedworkers have to allow for
the fact that few of the new employees
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stayed with the job for very long (27,28).
Whether those who remained in their jobs
were the most hardy is difficult to assess, but
they are not likely to be a random and rep-
resentative selection ofthe original groups.
Accordingly, prospective studies should not
be considered less critically than other epi-
demiologic studies.
When evaluating the epidemiologic
evidence, several factors should be consid-
ered that could potentially bias the results
toward the null hypothesis (29). With the
inherent biases and possibilities of mis-
classification, epidemiologic studies will
always reveal shadows that must be inter-
preted from all available evidence as reflec-
tions of the truth. Statistical significance
should be interpreted in the light ofsam-
ple size and the ranges ofvariation. Thus,
a study that fails to document a statisti-
cally significant association should not
necessarily be considered as evidence that
an association is absent, i.e., the study is
nonpositive rather than negative. However,
the main problem in risk assessment is that
dose-relationships, whenever indicated by
epidemiologic data, are usually associated
with immense confidence limits. A main
problem is whether regression equations
should assume the existence ofa threshold
below which an exposure will not cause
any discernible effect.
One final observation should be made.
Risk assessment must necessarily include
considerable amounts ofsubjectivity, e.g., in
the choice ofsource population, the para-
meters to be assessed, and the inference
made with regard to the significance ofthe
observed changes to human health (30).
This is true in neurobehavioral epidemiol-
ogy as in other disciplines that provide data
for risk assessment. While recognizing the
fact that decision making in environmental
health must take into account ethical, social,
economic, and political aspects, neurobe-
havioral epidemiology can contribute
important information that should be inter-
preted and used in the proper context.
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